Cite
HARVARD Citation
Ogawara, D. et al. (2018). Presence of few PD‐1‐expressing tumor‐infiltrating immune cells is a potential predictor of improved response to salvage chemotherapy following nivolumab for non‐small cell lung cancer: An exploratory case series. Thoracic cancer. 9 (10), pp. 1305-1311. [Online].